Refine
Year of publication
Document Type
- Article (21)
- Conference Proceeding (6)
- Review (3)
- Postprint (2)
- Other (1)
Language
- English (33)
Is part of the Bibliography
- yes (33)
Keywords
- diabetic nephropathy (3)
- linagliptin (3)
- Epigenetics (2)
- Free vitamin D (2)
- Vitamin D-binding protein (2)
- chronic kidney disease (2)
- eNOS (2)
- proteomic analysis (2)
- 1,25(OH)(2) vitamin D (1)
- 25-OH vitamin D (1)
- 2k1c renovascular hypertension (1)
- Bioavailable vitamin D (1)
- Blood pressure (1)
- Calculated free 25(OH) vitamin D (1)
- Calculated free 25-hydroxyvitamin D (1)
- Chronic kidney disease (1)
- Clinical trials (1)
- Contrast induced acute kidney injury (1)
- Coronary angiography (1)
- DNA methylation (1)
- DPP-4 inhibition (1)
- DPP-4 inhibitor (1)
- DPP-4 inhibitors (1)
- DPP4 inhibition (1)
- Diabetic nephropathy (1)
- Directly measured free vitamin D (1)
- Endothelial nitric oxide synthase (1)
- Endothelin (1)
- Endothelin receptor antagonists (1)
- Endothelin-1 transgenic mice (1)
- Fetal programming (1)
- Free 25(OH) vitamin D (1)
- Genetic polymorphism (1)
- Gestational diabetes mellitus (1)
- Glp1r(-/-) mice (1)
- Glucocorticoid receptor (1)
- Glucose tolerance (1)
- HNRNPA1 (1)
- Heart weight (1)
- High-fat-sucrose-salt diet (1)
- Insulin resistance (1)
- Kidney (1)
- Kidney weight (1)
- Kynurenine (1)
- Linagliptin (1)
- Long term health (1)
- Major adverse kidney event (1)
- Maternal folate treatment (1)
- Measured free 25-hydroxyvitamin D (1)
- Mice (1)
- NGAL (1)
- Nitric oxide (1)
- PGC1a (1)
- Paternal programming (1)
- Paternal programming; (1)
- Preeclampsia (1)
- Pregnancy (1)
- Preinterventional biomarker (1)
- Reference intervals (1)
- Renin-angiotensin system (1)
- Safety (1)
- Side effects (1)
- Single nucleotide polymorphism (1)
- Small for gestational age (1)
- TGF-beta 1 (1)
- Total 25(OH) vitamin D (1)
- Vitamin D binding protein (1)
- Vitamin D deficiency (1)
- Water and salt retention (1)
- YB-1 (1)
- acute kidney injury (1)
- albuminuria (1)
- angiotensin receptor blockers (1)
- blood biomarker (1)
- blood pressure (1)
- capillary blood (1)
- cardiac surgery (1)
- cardiometabolic diseases (1)
- clusterin (1)
- collagen I (1)
- comparison (1)
- diabetic control (1)
- disease (1)
- early diagnosis (1)
- epigenetics (1)
- failure (1)
- fatty liver (1)
- fibrosis (1)
- filter paper (1)
- guanylate cyclase (1)
- heart-type fatty acid binding protein (1)
- intervention (1)
- kidney injury molecule 1 (1)
- large sample size studies (1)
- metabolism (1)
- molecule-1 KIM-1 (1)
- nephrin (1)
- neutrophil gelatinase-associated lipocalin (1)
- new analysis method (1)
- offspring (1)
- one dot two development signals (ODTDS) dot blot (1)
- osteopontin (1)
- oxidative stress (1)
- paternal programming (1)
- protein quantification (1)
- proteinuria (1)
- pulmonary hypertension (1)
- spermatogenesis (1)
- telmisartan (1)
- thymosin beta 4 (1)
- tissue inhibitior of metalloproteinases 1 (1)
- transgenerational effects (1)
- urinary biomarker (1)
- western blot (1)
New data from the LEADER trial show that the glucagon-like peptide 1 receptor agonist liraglutide protects against diabetic nephropathy in patients with type 2 diabetes mellitus. The renoprotective efficacy of liraglutide is not, however, as great as that reported for the sodium-glucose cotransporter 2 inhibitor emplagiflozin in the EMPA-REG OUTCOME trial.